SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomas.

Saved in:
Bibliographic Details
Title: SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomas.
Authors: Karanian-Philippe M; Department of BioPathology §Medical Oncology **Surgery, Institut Bergonié †INSERM U916 ‡Université de Bordeaux, Bordeaux ∥Department of Pathology, Centre JF Leclerc, Comprehensive Cancer Centre, Dijon ¶Department of Pathology, University Hospital of Caen, Caen #Department of Pathology, University Hospital of Strasbourg, Strasbourg, France., Velasco V, Longy M, Floquet A, Arnould L, Coindre JM, Le Naoures-Méar C, Averous G, Guyon F, MacGrogan G, Croce S
Source: The American journal of surgical pathology [Am J Surg Pathol] 2015 Sep; Vol. 39 (9), pp. 1197-205.
Publication Type: Comparative Study; Evaluation Study; Journal Article
Journal Info: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 7707904 Publication Model: Print Cited Medium: Internet ISSN: 1532-0979 (Electronic) Linking ISSN: 01475185 NLM ISO Abbreviation: Am J Surg Pathol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-0979
DOI:10.1097/PAS.0000000000000475